The present invention provides pharmaceutical adenovirus formulations, in particular liquid pharmaceutical formulations comprising adenoviruses.L'invention concerne des formulations pharmaceutiques d'adénovirus, en particulier des formulations pharmaceutiques liquides comprenant des adénovirus.